Riskpilot← Back to searchSign inGet full accessSKIPTVET APOTEK AS
ASActiveOrg 913311973Storveien 7, 1816 SkiptvetRetail sale of pharmaceutical products · NACE 4773Est. 20140 employees
Revenue 2023
NOK 20,9M
+13% vs 2022
EBITDA margin
2.5%
+57% vs 2022
Equity ratio
12.1%
Financial strength
Net profit 2023
NOK 445K
+57% vs 2022
| Revenue | NOK 20,9M | +13% |
| EBITDA | NOK 523K | +57% |
| Net profit | NOK 445K | +57% |
| Total assets | NOK 5,5M | +72% |
| Equity | NOK 674K | +194% |
| Employees | 0 | — |
Legal name
SKIPTVET APOTEK AS
Org number
913311973
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
3. mars 2014
Share capital
NOK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder alene.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Address
Storveien 7, 1816 Skiptvet
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 13 107 | 16 573 | 19 221 | 18 567 | 20 928 |
| Staff expenses | −2 422 | −2 558 | −2 733 | −3 021 | −3 305 |
| EBITDA | 205 | 814 | 807 | 333 | 523 |
| Depreciation & amort. | −159 | −160 | −44 | −9 | −17 |
| EBIT | 46 | 654 | 763 | 324 | 506 |
| Net financials | 7 | 8 | 15 | 26 | 55 |
| Profit before tax | 53 | 663 | 778 | 350 | 561 |
| Tax | 24 | 168 | 168 | 68 | 116 |
| Net profit | 29 | 495 | 610 | 283 | 445 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 2 138 | 3 242 | 3 883 | 3 233 | 5 549 |
| Equity | 242 | 236 | 246 | 229 | 674 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 897 | 3 006 | 3 637 | 3 004 | 4 875 |
| Total debt | 1 897 | 3 006 | 3 637 | 3 004 | 4 875 |
EBITDA margin
2.5%
This company
15.8%
Market median
-84% vs market
20192023
Equity ratio
12.1%
This company
38.2%
Market median
-68% vs market
20192023
Return on equity
66.0%
This company
18.4%
Market median
+259% vs market
20192023
Net profit margin
2.1%
This company
8.1%
Market median
-74% vs market
20192023
Asset turnover
3.77×
This company
1.12×
Market median
+237% vs market
20192023
Debt / equity
7.24×
This company
0.62×
Market median
-1068% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
VH Contact Person | Contact Person | 2024 |
| Former (1) | ||
GA Chief Executive Officer | Chief Executive Officer | 2014 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (4) | ||
| Chairman | 2014 – 2024 | |
| Board of Directors | 2014 – 2024 | |
| Board of Directors | 2014 – 2024 | |
| Board of Directors | 2014 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 30% | 30% | 2023 | |
| Company | 25% | 25% | 2023 | |
| Company | 25% | 25% | 2023 | |
| Company | 20% | 20% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Apoinvest Holding As
SKIPTVET APOTEK AS Board members of SKIPTVET APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vegard Hoff | Contact Person | 0 companies |
| Gulzeb Aziz | Chief Executive Officer | 0 companies |
| Morten Frogner | Chairman | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |
| Kurt Leon Haga | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Board of Directors | 0 companies |
| Anders Øivind Lunde | Board of Directors | 0 companies |